In a joint statement issued by the World Health Organization (WHO), the group noted the urgency of delivering more doses of pandemic immunizers to low-income countries, where less than 2.5 percent of the population has completed the schedule.
It acknowledged progress in diversifying biologics development, with new partnerships in multiple regions of developing nations, and stressed the need to continue to strengthen such collaboration.
Senior officials from the International Monetary Fund, the World Bank, WHO and the World Trade Organization held a second consultation with the CEOs of major Covid-19 vaccine manufacturing companies the day before, according to the text.
The meeting sought to identify ways to ensure more equitable distribution of immunizers, and participants pledged to continue working together to obtain greater clarity on donations, it added.
The group discussed the outlook for 2022, focusing on diversifying manufacturing across regions, as well as strengthening collaboration to achieve the global goal of reaching 70 percent of people in every territory by mid-year.